Skip to main content
. 2015 Jun 4;4:125. doi: 10.4103/2277-9175.158040

Table 2.

Effect of the cGMP-specific PDE (PDE5) inhibitor, zaprinast, on the generation of histamine, IL-13 and IL-4 from basophils activated with IL-3

graphic file with name ABR-4-125-g006.jpg